about
Promising and delivering gene therapies for vision lossRetinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectorsGene therapy for choroideremia using an adeno-associated viral (AAV) vector.Gene therapy for retinal diseaseGene Therapy for Color Blindness.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An analysis of retinal gene therapy clinical trials.
@en
An analysis of retinal gene therapy clinical trials.
@nl
type
label
An analysis of retinal gene therapy clinical trials.
@en
An analysis of retinal gene therapy clinical trials.
@nl
prefLabel
An analysis of retinal gene therapy clinical trials.
@en
An analysis of retinal gene therapy clinical trials.
@nl
P2860
P1476
An analysis of retinal gene therapy clinical trials
@en
P2093
Robert E MacLaren
P2860
P304
P577
2009-10-01T00:00:00Z